clinical trials

A breakthrough in the treatment of drug-resistant TB signals shorter and safer treatment for patients

People battling rifampicin-resistant tuberculosis (RR-TB) could soon have access to a shorter and safer course of treatment. Doctors without Borders (MSF) have released the results from a clinical trial on an all oral six-month treatment regime. Current treatment can last…

Read More » A breakthrough in the treatment of drug-resistant TB signals shorter and safer treatment for patients

Newsletter Subscription